Conversely, overexpression of SELENOW reduces tau-related pathologies, including tau phosphorylation, neurofibrillary tangle formation, and neuroinflammation, ultimately improving memory function in AD models [187]. This evidence concerns the gene MAPT and Alzheimer disease.